Stryker appoints a new head for its India operations

By Catherine Sturman
Share
Leading medical technology company Stryker has revealed that it has appointed Meenakshi Nevatia as the company’s new managing director within its oper...

Leading medical technology company Stryker has revealed that it has appointed Meenakshi Nevatia as the company’s new managing director within its operations in India.

Asia is fast becoming one of the most promising markets. With an ageing population, increased pressures on healthcare organisations are leading health tech companies to view the area’s lucrative, long-term potential, particularly with the launch of its National Health Protection Scheme, Ayushman Bharat.

Responsible for driving the company’s business strategy, and extend the company’s footprint across the Indian market.

With extensive experience working for healthcare giant Novartis, Nevatia is well placed in tackling the challenges which entering a new market will bring to the business.

See also

"Customers and patients are at the heart of everything we do, and I look forward to bringing together our team to do more to improve lives in India," she said.

"I also look forward to creating an environment where our people, one of our core values, can continue to thrive and grow.”

Additionally, Nevatia has a Master in Business Administration in Strategy and Finance from the Indian Institute of Management, Ahmedabad, and Bachelor of Science in Economics and Mathematics from the Presidency College, Kolkata.

The news follows on from the company’s recent acquisition of HyperBranch Medical Technology, Inc., as part of its long-term growth strategy.

Share

Featured Articles

How Huawei's Digital Solutions are Transforming Healthcare

Offering network, cloud, and AI solutions, Huawei is able to help healthcare providers deliver better outcomes for patients

2024 Nestlé Nutrition Symposium Explored Food & Health

Nestlé manufactures 4.5m KitKats every day, but the food giant is also focused on advancing food nutrition, as explored at the 2024 International Symposium

Thirona’s AI Tech is Creating Individualised Patient Care

Eva van Rikxoort, CEO and Founder of Thirona, tells us how AI technology is advancing lung imaging and bringing more individualised treatment to patients

AstraZeneca’s Discovery Centre, Constructed by Mace Group

Technology & AI

NeoGenomics: Data in Oncology Testing & Diagnostics

AI & ML

Samsung’s New Health Software Development Kit Suite

Digital Healthcare